Opportunity Information: Apply for PAR 23 303
This NIH funding opportunity (PAR-23-303) uses the R01 grant mechanism to support research that clarifies and helps reduce health and health care disparities tied to non-communicable and chronic diseases (NCDs) that drive the greatest burden of illness and mortality in Latin America and among U.S. Hispanic/Latino populations. The emphasis is on producing rigorous evidence that can explain why disparities persist, how they vary across settings and populations, and which levers in health systems or policy environments could realistically improve outcomes. Clinical trials are not allowed under this NOFO, so the program is aimed at observational, analytic, measurement, and policy-focused research rather than testing new interventions in trial formats.
The scope is intentionally multi-disciplinary and collaborative. NIH is looking for teams that can bring together expertise such as clinical epidemiology, biostatistics, health services research, implementation or dissemination science (when not framed as a clinical trial), economics, sociology, political science, and measurement science, depending on the scientific questions. Projects are expected to do more than run parallel analyses; they should integrate perspectives and methods in a way that meaningfully advances understanding of disparities in disease risk, diagnosis, treatment, quality of care, and outcomes across the life course. The NOFO highlights three broad research areas that fit well: clinical epidemiology to quantify and explain inequities in NCDs; evaluation of public policies and/or health care policies that shape access and quality; and validation of measurements, meaning development, adaptation, testing, or calibration of tools and metrics used to capture exposures, outcomes, and inequity-related constructs across countries and cultures.
A central requirement is strong partnership with Latin America. Applications are expected to include genuine collaboration with key partners, and the team must include at least one Principal Investigator or Multiple Principal Investigator based at an institution in Latin America. This design is meant to ensure that research questions, data, measurement approaches, and interpretations reflect local context and priorities, and that the work contributes to capacity and sustained collaboration across the hemisphere. While the project focus is on Latin America and U.S. Hispanics/Latinos, the broader goal is to set the stage for better population health outcomes across the hemisphere by generating actionable evidence on where inequities arise and how systems and policies might be improved.
Eligibility is broad across U.S.-based organizations and includes many government and non-government entities. Eligible applicants include state, county, city/township, and special district governments; federally recognized tribal governments and other tribal organizations; public and private institutions of higher education; independent school districts; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other eligible entities. The NOFO also explicitly notes interest in participation from organizations that often serve communities experiencing disparities, including Hispanic-serving institutions, Historically Black Colleges and Universities, Tribally Controlled Colleges and Universities, Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions, as well as eligible federal agencies.
At the same time, there are important restrictions related to foreign applications. Non-domestic (non-U.S.) entities and non-domestic (non-U.S.) institutions are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components are allowed as defined in the NIH Grants Policy Statement, which typically means a U.S. applicant can include certain project elements conducted outside the U.S. when appropriately justified and structured, consistent with NIH rules, and in line with the required collaboration with Latin American investigators and institutions.
Administratively, this is a discretionary grant opportunity from the National Institutes of Health under the R01 funding instrument, categorized under education and health. The NOFO lists CFDA numbers 93.307, 93.313, 93.361, 93.393, and 93.866. The opportunity was created on October 12, 2023, and the original closing date shown is January 6, 2027. The award ceiling and expected number of awards are not specified in the provided source information, which is common for some NIH announcements where budgets are proposed based on project needs and must align with NIH and institute-specific policies.
Overall, the opportunity is designed for applicants who can assemble cross-disciplinary teams and build equitable, real partnerships with Latin American investigators to produce high-quality evidence on chronic disease disparities. Competitive projects will typically be those that can link robust epidemiologic or health services methods with policy-relevant questions and culturally and contextually valid measurement, generating insights that health systems, policymakers, and communities can actually use to reduce inequities in NCD prevention, care, and outcomes.Apply for PAR 23 303
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.307, 93.313, 93.361, 93.393, 93.866.
- This funding opportunity was created on 2023-10-12.
- Applicants must submit their applications by 2027-01-06.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education, Health
Next opportunity: 2024 Dual Use Technology Development at Marshall Space Flight Center
Previous opportunity: Cohort Studies of HIV/AIDS and Substance Use (U01 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 23 303
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 23 303) also looked into and applied for these:
| Funding Opportunity |
|---|
| Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional) Apply for RFA CA 24 006 Funding Number: RFA CA 24 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Applying Imaging Pipelines for Spatial Characterization of Cellular Interactions in HIV-related CNS Pathology and/or Substance Use (R61/R33 Clinical Trial Not Allowed) Apply for RFA DA 24 030 Funding Number: RFA DA 24 030 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed) Apply for RFA DA 25 012 Funding Number: RFA DA 25 012 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed) Apply for RFA DA 25 013 Funding Number: RFA DA 25 013 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Tools for decentralized clinical trials for substance use disorder (R43/R44 Clinical Trials Optional) Apply for RFA DA 25 052 Funding Number: RFA DA 25 052 Agency: National Institutes of Health Category: Education, Health Funding Amount: $295,924 |
| Tools for Decentralized Clinical Trials for Substance Use Disorder (R41/R42 Clinical Trials Optional) Apply for RFA DA 25 051 Funding Number: RFA DA 25 051 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,972,828 |
| Resource Center for Cannabis and Cannabinoid Research (U24 Clinical Trial Not Allowed) Apply for RFA AT 24 006 Funding Number: RFA AT 24 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: $850,000 |
| Effect of HIV and Substance Use Comorbidity on the Placenta and Maternal Outcomes (R01 Clinical Trial Optional) Apply for RFA DA 25 021 Funding Number: RFA DA 25 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Short Courses in Social Determinants of Health for Research Education in Nursing Research (R25 Independent Clinical Trial Not Allowed) Apply for RFA NR 24 002 Funding Number: RFA NR 24 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Advancing Technologies to Improve Delivery of Pharmacological, Gene Editing, and other Cargoes for HIV and SUD Mechanistic or Therapeutic Research (R01 Clinical Trial Optional) Apply for RFA DA 25 022 Funding Number: RFA DA 25 022 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) Apply for PAR 24 039 Funding Number: PAR 24 039 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Psychedelics Treatment Research in Substance Use Disorder (UG3/UH3 Clinical Trials Optional) Apply for RFA DA 25 058 Funding Number: RFA DA 25 058 Agency: National Institutes of Health Category: Education, Health Funding Amount: $2,000,000 |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) Apply for PAR 23 314 Funding Number: PAR 23 314 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) Apply for PAR 23 313 Funding Number: PAR 23 313 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Single Source: AIDS and Cancer Specimen Resource (ACSR; UM1 Clinical Trials Not Allowed) Apply for RFA CA 23 043 Funding Number: RFA CA 23 043 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advancing Genomic Medicine Research (R01 Clinical Trial Optional) Apply for RFA HG 23 032 Funding Number: RFA HG 23 032 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities (UG3/UH3, Clinical Trial Required) Apply for PAR 24 053 Funding Number: PAR 24 053 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advancing Genomic Medicine Research (R21 Clinical Trial Optional) Apply for RFA HG 23 033 Funding Number: RFA HG 23 033 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Rural Community-Centered Drug Misuse Prevention and Harm Reduction Research: Addressing Implementation, Dissemination, and Equity Challenges across the Continuum of Care (R61/R33 Clinical Trial Only) Apply for RFA DA 24 036 Funding Number: RFA DA 24 036 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional) Apply for PAR 24 062 Funding Number: PAR 24 062 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 23 303", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
